Monday, February 24, 2020

Inari Medical Files For IPO

Irvine-based Inari Medical, a developer of medical devices used to extract clots from blood vessels, has filed for an IPO. The company says it is looking to raise up to $100M in an IPO on the Nasdaq Global Market as NARI. The IPO is being unerwritten by BofA Securities, Morgan Stanley, Canaccord Genuity, and Wells Fargo Securities. The company's major venture backers are U.S. Venture Partners (20.0% ownership before the IPO); Gilde Healthcare (19.6%), Versant Venture Capital (14.9%), Mildet Community Property Trust (13.0%), and Crown Venture Fund (8.9%). The company is led by CEO William Hoffman. According to the filing, the company is being represented by Latham & Watkins LLP and audited by BDO LLP.

---